Drug intelligence / Profile preview

mmu_circ_0002215-ASO

Development stage
Preclinical
Lead developer
Wannan Medical College
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

mmu_circ_0002215-ASO is an antisense oligonucleotide (ASO) designed to target and suppress the circular RNA mmu_circ_0002215, which is the mouse homolog of human hsa_circ_0008925. Developed by researchers at Wannan Medical College, this therapeutic candidate is being investigated for the treatment of chronic kidney disease (CKD) and renal fibrosis. In preclinical models of unilateral ureteral obstruction (UUO), the ASO is delivered specifically to injured kidneys using engineered exosomes decorated with a Kim-1-targeting LTH peptide. This targeted delivery suppresses mmu_circ_0002215 expression, leading to a reduction in renal collagen deposition, tubular injury, and alpha-SMA expression, thereby attenuating renal fibrosis.

02

Targets

SRSF6mmu_circ_0002215 (Circular RNA mmu_circ_0002215)

Beyond the preview

Go deeper on mmu_circ_0002215-ASO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mmu_circ_0002215-ASO.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call